Tag: R/R MCL treatment

Home / R/R MCL treatment

Categories

Lisocabtagene maraleucel is approved by FDA for relapsed or refractory mantle cell lymphoma

May 2024: The Food and Drug Administration has granted approval to lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) for the treatment of adult patients with relapsed or refractory mantle c...
r-r-mcl-treatment

Scan the code